Report from the Annual General Meeting of Vitrolife AB (publ)

The Annual General Meeting resolved to discharge the Board members and the Chief Executive Officer from liability for the financial year 2025.

The Annual General Meeting also resolved to:

• approve the Board's remuneration report for the financial year 2025;
  
  
• determine remuneration to the Board members as follows: SEK 1,350,000 to the Chairman of the Board, SEK 450,000 to each of the other Board members, SEK 160,000 to the Chairman and SEK 80,000 each to the other members of the Audit Committee, as well as SEK 100,000 to the Chairman and SEK 50,000 each to the other members of the Remuneration Committee;
  
  
• re-elect Deloitte AB as Auditor for the period until the end of the next Annual General Meeting, with the authorised public accountant Anneli Pihl as Auditor in Charge;
  
  
• determine that remuneration to the Auditor shall be paid in accordance with approved invoices;
  
  
• adopt procedure of the Nomination Committee;
  
  
• adopt a long-term share incentive plan, including issue and transfer of warrants to the participants or to a third party;
  
  
• authorise the Board to, on one or more occasions during the period until the next Annual General Meeting, with or without deviation from the shareholders' preferential rights, resolve on new issues of shares, in accordance with the terms and conditions set out in further detail in the Board's proposal;
  
  
• authorise the Board to, on one or more occasions during the period until the next Annual General Meeting, resolve on acquisitions of own shares, in accordance with the terms and conditions set out in further detail in the Board's proposal; and
  
  
• amend the Articles of Association in accordance with the details set out in the Board's proposal.

The information was submitted for publication, through the agency of the contact persons set out above, at 05-05-2026 18:30 CET.